Cetuximab

• CAT Number: M000073
• CAS Number: 205923-56-4
• Molecular Formula: C6484H10042N1732O2023S36
• Molecular Weight: 145779.44
• Purity: ≥95%
• Synonyms: CETUXIMAB;Erbitux;Hsdb 7454;Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 gamma1-chain), disulfide with human-mouse monoclonal C225 kappa-chain, dimer;Unii-pqx0D8J21j;EGFR antibody;IMC 225;CetuxiMab(C22
• Target: Protein Tyrosine Kinase/RTK
• Storage: Room temperature

Cetuximab(CAT: M000073) is a chimeric monoclonal antibody targeting the epidermal growth factor receptor (EGFR), a protein that plays a crucial role in cell growth and proliferation. By binding to EGFR, cetuximab inhibits the receptor’s activity, effectively blocking the signaling pathways that promote tumor growth and survival. This mechanism of action makes cetuximab an important therapeutic agent in the treatment of certain cancers, including colorectal cancer and head and neck squamous cell carcinoma.